Evidence method
Level · gp.fundamentals.debt_to_revenue
161.40% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HBIO · Jun 30, 2026
HARVARD BIOSCIENCE INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001171843-26-005425General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
3.03% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
1.43% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
11.13% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
97.81% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
55.57% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-4.30% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.79% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.67% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/9 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20248/9 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20259/9 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 174.47%
- Current
- 161.40%
- Delta
- -13.07%
- Previous
- 2.05%
- Current
- 3.03%
- Delta
- 0.97%
- Previous
- -3.19%
- Current
- 1.43%
- Delta
- 4.62%
- Previous
- -4.68%
- Current
- 11.13%
- Delta
- 15.81%
- Previous
- 106.99%
- Current
- 97.81%
- Delta
- -9.17%
- Previous
- 58.99%
- Current
- 55.57%
- Delta
- -3.42%
- Previous
- -5.66%
- Current
- -4.30%
- Delta
- 1.35%
- Previous
- 11.21%
- Current
- 10.79%
- Delta
- -0.41%
- Previous
- 1.24%
- Current
- 1.67%
- Delta
- 0.43%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Laboratory Analytical Instruments peers →Has State · HARVARD BIOSCIENCE INC →Transitioned To · HBIO Fundamental State →Transitioned To · HBIO BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · HBIO CAPEX_INTENSITY_INCREASED →Transitioned To · HBIO CASH_GENERATION_INCREASED →Transitioned To · HBIO GROWTH_INCREASED →Transitioned To · HBIO INVENTORY_PRESSURE_DECREASED →Transitioned To · HBIO MARGIN_DECREASED →Transitioned To · HBIO PROFITABILITY_INCREASED →Transitioned To · HBIO R_AND_D_INTENSITY_DECREASED →Transitioned To · HBIO SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.